SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-15-084716
Filing Date
2015-12-15
Accepted
2015-12-14 17:41:27
Documents
5
Period of Report
2016-02-04
Effectiveness Date
2015-12-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a15-24921_1def14a.htm DEF 14A 336149
2 GRAPHIC g249211bii001.jpg GRAPHIC 6281
3 GRAPHIC g249211boi001.gif GRAPHIC 56073
4 GRAPHIC g249211boi002.gif GRAPHIC 24551
5 GRAPHIC g249211bci001.jpg GRAPHIC 6089
  Complete submission text file 0001104659-15-084716.txt   465774
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36856 | Film No.: 151286852
SIC: 2834 Pharmaceutical Preparations